The Biotechnology Goldrush

Available for over a year

Who should 'own' new therapies, medicines and procedures that result from human genes, DNA and advances in biotechnology? Should human DNA be patented? With Anya Sitaram and Sanjida O'Connell, and also Andrew Sheard patent attorney and chairman of the Intellectual Property Advisory Committee of the BioIndustry Association; Sue Mayer of GeneWatch UK; and Alastair Kent of Genetic Alliance.